Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]

Retraction Statement: When reviewing the data and article, we found that some of the data or writing in the above article were not scientific enough. First, the normal hepatocyte cell lines we used were L02, as shown in Figure 3A, but it was written as THLE-3 cells in the Method section by mistake. Second, the internal reference antibody in Western blot analysis was GAPDH instead of β-actin, which was listed in the article. Those mistakes may lead to the researchers’ wrong interpretation of the data and misjudgment of its scientific nature. For these reasons, the authors have decided to retract the article from the publication. All the named authors on the article agree to this retraction. The authors sincerely apologize for any inconvenience that might result from the retraction of this article.